Becker's Healthcare May 13, 2022
Naomi Diaz

New York City-based Memorial Sloan Kettering Cancer Center researchers’ AI sensor, trained to identify ovarian cancer, was found to be more effective than currently used methods for early detection.

The cancer detection technology, which uses an array of sensors made of carbon nanotubes that can detect certain molecules in a blood sample, combined with a machine-learning algorithm to identify a cancer fingerprint, was used in an experiment using blood samples obtained from patients with ovarian cancer, according to a May 13 press release.

Researchers found that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Technology
Brave launches a real-time privacy-focused AI answer engine
Watch out, Boston Dynamics! Mentee Robotics unveils 'AI-first' robot
The Use of Artificial Intelligence in Lung Cancer Management
Responsible AI Requires a Delicate Balancing Act
UniDoc Brings AI-Powered Health Cube to Alaska

Share This Article